1. Epigenetic Regulation of Inflammatory Cytokines and Associated Genes in Human Malignancies
    Rehana Yasmin et al, 2015, Mediators of Inflammation CrossRef
  2. Methylation-mediated gene silencing as biomarkers of gastric cancer: A review
    Jun Nakamura, 2014, WJG CrossRef
  3. Expression and effect of CXCL14 in colorectal carcinoma
    KEZHI LIN et al, 2014 CrossRef
  4. Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma
    T Kondo et al, 2016, Oncogenesis CrossRef
  5. Cancer Drug Repositioning by Comparison of Gene Expression in Humans and Axolotl (Ambystoma mexicanum) During Wound Healing
    Elif Kubat Öktem et al, 2019, OMICS: A Journal of Integrative Biology CrossRef
  6. Promoter methylation and expression of theVANGL2gene in the myocardium of pediatric patients with Tetralogy of Fallot
    Yuan Yuan et al, 2014, Birth Defects Research Part A: Clinical and Molecular Teratology CrossRef
  7. CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8+ T-cell responses by upregulating MHC-I expression
    Joseph A. Westrich et al, 2019, Oncogene CrossRef
  8. DNA Methylation Profile of Genes Involved in Inflammation and Autoimmunity in Inflammatory Bowel Disease
    Pantelis S. Karatzas et al, 2014, Medicine CrossRef
  9. Comparison of Gene Expression Profile Between Tumor Tissue and Adjacent Non-tumor Tissue in Patients with Gastric Gastrointestinal Stromal Tumor (GIST)
    Youwei Kou et al, 2015, Cell Biochem Biophys CrossRef
  10. Chemokine CXCL14 is a multistep tumor suppressor
    Xiao-Yan Yang et al, 2016, Journal of Oral Biosciences CrossRef
  11. CXCL14 as an emerging immune and inflammatory modulator
    Jing Lu et al, 2016, J Inflamm CrossRef
  12. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma
    Fuqiang Yin et al, 2016, J Exp Clin Cancer Res CrossRef
  13. Epigenetic and genetic deregulation in cancer target distinct signaling pathway domains.
    Yang Gao et al, 2017, Nucleic Acids Res CrossRef
  14. Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer
    Osmel Companioni et al, 2017, PLoS ONE CrossRef
  15. The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses
    Joseph A. Westrich et al, 2020, Molecular Carcinogenesis CrossRef
  16. Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma
    Jinyan Liu et al, 2015, Oncotarget CrossRef
  17. Two coupled mutations abolished the binding of CEBPB to the promoter of CXCL14 that displayed an antiviral effect on PRRSV by activating IFN signaling
    Lizhu Niu et al, 2020, The FASEB Journal CrossRef
  18. Chemokine CXCL14; a double-edged sword in cancer development
    Arezoo Gowhari Shabgah et al, 2021, International Immunopharmacology CrossRef
  19. Dysregulation of CXCL14 promotes malignant phenotypes of esophageal squamous carcinoma cells via regulating SRC and EGFR signaling.
    Jing Guo et al, 2022, Biochem Biophys Res Commun CrossRef
  20. Epigenetic Perspective of Immunotherapy for Cancers
    Sunita Keshari et al, 2023, Cells CrossRef
  21. Data Mining Suggests That CXCL14 Gene Silencing in Colon Cancer Is Due to Promoter Methylation
    Yanjing Wang et al, 2023, IJMS CrossRef
  22. Involvement of CXC chemokines (CXCL1-CXCL17) in gastric cancer: Prognosis and therapeutic molecules
    Amin Ullah et al, 2024, Life Sciences CrossRef
  23. Epigenetic modulation of cytokine expression in gastric cancer: influence on angiogenesis, metastasis and chemoresistance
    María Elena Reyes et al, 2024, Front. Immunol. CrossRef